Skip to main content
. 2021 May 20;9:669173. doi: 10.3389/fpubh.2021.669173

Table 2.

The MIC of 31 CRKp isolates and two transconjugants (μg/mL).

No. SAM TZP ATM CRO CAZ FEP FOX ETP IMP MEM SXT CIP LEV CN AK TGC CO
Kp1 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≥16/304 ≥4 ≥8 ≤ 1 ≤ 2 1 0.25
Kp2 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≤ 1 ≤ 2 0.5 0.25
Kp3 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.25 1
Kp4 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≥16/304 ≥4 ≥8 ≥16 ≥64 0.5 0.5
Kp5 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.5 0.5
Kp6 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.25 0.5
Kp7 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.5 0.5
Kp8 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 1 0.5
Kp9 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 1 1
Kp10 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≥16/304 ≥4 ≥8 ≥16 ≥64 0.25 0.5
Kp11 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.5 1
Kp12 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.5 0.25
Kp13 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.5 0.25
Kp14 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.25 0.5
Kp15 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.25 0.5
Kp16 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.25 0.5
Kp17 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.25 0.25
Kp18 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.5 0.25
Kp19 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≤ 1 ≤ 2 0.5 0.5
Kp20 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.25 0.5
Kp21 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≤ 1 ≤ 2 0.5 0.5
Kp22 >16/8 ≥128 ≤ 4 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 1 0.5
Kp23 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 1 0.5
Kp24 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.25 1
Kp25 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.5 0.5
Kp26 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≥16/304 ≥4 ≥8 ≥16 ≥64 0.5 1
Kp27 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≤ 0.25 ≤ 0.25 ≤ 1 ≤ 2 1 0.25
Kp28 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.5 0.25
Kp29 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.25 1
Kp30 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≥16 ≥64 0.5 0.5
Kp31 >16/8 ≥128 >16 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≥4 ≥8 ≤ 1 ≤ 2 0.5 0.5
J22 >16/8 ≥128 ≤ 4 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≤ 0.25 ≤ 0.25 ≤ 1 ≤ 2 0.125 0.125
J27 >16/8 ≥128 ≤ 4 ≥64 ≥64 ≥64 >16 >32 >32 >32 ≤ 1/19 ≤ 0.25 ≤ 0.25 ≤ 1 ≤ 2 0.125 0.125

MIC, Minimum inhibitory concentration; SAM, ampicillin sulbactam; TZP, piperacillin/tazobactam; ATM, aztreonam; CRO, ceftriaxone; CAZ, ceftazidime; FEP, cefepime; FOX, cefoxitin; ETP, ertapenem; IPM, imipenem; MEM, meropenem; SXT, trimethoprim-sulfamethoxazole; CIP, ciprofloxacin; LEV, levofloxacin; CN, gentamicin; AK, amikacin; TGC, tigecycline; CO, colisin.